Literature DB >> 29142661

Adverse effects of electroconvulsive therapy on cognitive performance.

Sasha S Getty1, Lawrence R Faziola2.   

Abstract

Entities:  

Keywords:  cognitive performance; electroconvulsive therapy

Year:  2017        PMID: 29142661      PMCID: PMC5661121          DOI: 10.4081/mi.2017.7181

Source DB:  PubMed          Journal:  Ment Illn        ISSN: 2036-7457


× No keyword cloud information.

Competing interest statement

Conflict of interest: the authors declare no potential conflict of interest.

Electroconvulsive therapy (ECT) has historically been shown to be a highly effective method of treating major depression and catatonic state otherwise resistant to psychopharmacotherapy. [1-5] However, ECT has also been associated with a variety of transient impairments in cognitive performance during and following the treatment.[6-10] The side effects, often subjectively reported by the patients, include deficits in orientation, short term memory function, attention, speech fluency, and executive functions lasting from hours to perhaps months in a number of cases.[6-10] These reported attributes often lead to limited use of ECT as an acute treatment of treatment-resistant depression and other conditions where it can potentially produce positive overturning effects. There appears to be a lack of clarity and consensus in the literature regarding ECT-related adverse effects on cognitive performance. While some studies have reported absence of any effects on memory and implicit learning,[6] several others have shown diverse negative impacts across various domains of cognition including greatest global decline associated with bitemporal ECT, major deterioration of verbal memory attributed to bifrontal ECT, and largest decline in visual memory related to right unilateral ECT, as measured by tests such as Mini Mental State exam,[7] Trail- Making,[11,12] Rey Auditory Verbal Learning,[11,12] autobiographical memory, visual memory, and verbal fluency.[11,13] Therefore, this topic remains much debatable, and can still benefit from investigations that would add to the body of evidence to further elucidate and clarify different aspects and extent of these adverse effects in terms of factors such as distinction between immediate versus delayed impacts, different electrode placement methods and dosing, as well as the appropriate measurement methods sensitive to particular cognitive domains. Authors of this study[14] investigated the potential immediate short-term adverse effect of right unilateral ECT on cognitive function using digital ascending number tapping test (DANTT) as a novel psychometric measurement modality. Using DANNT, the authors specifically studied speed of processing, executive function, and visual search before and after treatment in patients of both genders between the ages of 36 to 76 years. They concluded that ECT does not significantly alter cognitive performance in those domains up to 2 hours after receiving therapy, which is in stark contrast to the results of previous investigations. [14] Results of this study revealed no measurable impairment of concentration resulting from single or multiple ECT treatments. In addition, patients with a longer seizure duration elicited by ECT did not exhibit greater concentration impairment as evidenced by absence of any significant difference in performance times.[14] Adverse effects of ECT on cognitive function has been the subject of investigation in several studies. However, current literature does not provide sufficient and specific data in order to draw reliable conclusions as to the degree and extent of potential impairments in various particular domains of cognitive performance.[1-13] In contrast to previous studies, this study did not reveal any significant post-ECT deficit in select cognitive domains, namely speed of processing, executive function, and visual search as measured by DANNT.[14] This finding raises the possibility that perhaps some elements of cognition may be immune to ECT, whereas other domains, shown to have exhibited deficits in other studies, might be more susceptible. This demands further subtyping of cognitive domains and deficits, as well as designing measurement tools tailored to more accurately and specifically target those areas. Use of DANTT introduced in this study in lieu of tests used in previous studies such as trail-making and MMSE, which provide only an overall score without localizing function to particular cognitive domains, is an example of this approach. This novel modality for measuring visual search and speed of processing in particular allows for higher precision and accuracy by eliminating problems associated with trail-making test such as memorization biases and line drawing which can hinder identification of numbers, and can be employed in future trials to reproduce the findings of this study.
  14 in total

Review 1.  Efficacy of ECT in depression: a meta-analytic review.

Authors:  Daniel Pagnin; Valéria de Queiroz; Stefano Pini; Giovanni Battista Cassano
Journal:  J ECT       Date:  2004-03       Impact factor: 3.635

2.  [The efficacy of ECT treatment in depression: a meta-analysis].

Authors:  Gazdag Gábor; Tringer László
Journal:  Psychiatr Hung       Date:  2005

3.  Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.

Authors:  Charles H Kellner; Rebecca Knapp; Mustafa M Husain; Keith Rasmussen; Shirlene Sampson; Munro Cullum; Shawn M McClintock; Kristen G Tobias; Celena Martino; Martina Mueller; Samuel H Bailine; Max Fink; Georgios Petrides
Journal:  Br J Psychiatry       Date:  2010-03       Impact factor: 9.319

Review 4.  Adverse Effects of Electroconvulsive Therapy.

Authors:  Chittaranjan Andrade; Shyam Sundar Arumugham; Jagadisha Thirthalli
Journal:  Psychiatr Clin North Am       Date:  2016-06-25

5.  Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression.

Authors:  Gerhard W Eschweiler; Reinhard Vonthein; Ruediger Bode; Michael Huell; Andreas Conca; Oliver Peters; Stefan Mende-Lechler; Julia Peters; Dorothee Klecha; Michael Prapotnik; Jan DiPauli; Barbara Wild; Christian Plewnia; Mathias Bartels; Wilfried Schlotter
Journal:  J Affect Disord       Date:  2006-12-28       Impact factor: 4.839

Review 6.  Therapy-resistant depression.

Authors:  Tom Bschor
Journal:  Expert Rev Neurother       Date:  2010-01       Impact factor: 4.618

Review 7.  Chronic and treatment resistant depression: diagnosis and stepwise therapy.

Authors:  Tom Bschor; Michael Bauer; Mazda Adli
Journal:  Dtsch Arztebl Int       Date:  2014-11-07       Impact factor: 5.594

8.  The acute and medium-term effects of treatment with electroconvulsive therapy on memory in patients with major depressive disorder.

Authors:  N P Maric; Z Stojanovic; S Andric; I Soldatovic; M Dolic; Z Spiric
Journal:  Psychol Med       Date:  2015-10-23       Impact factor: 7.723

9.  Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects.

Authors:  P Sienaert; K Vansteelandt; K Demyttenaere; J Peuskens
Journal:  J Affect Disord       Date:  2009-07-05       Impact factor: 4.839

10.  [Working memory disturbances in patients with major depression after ECT treatment].

Authors:  Wojciech Datka; Marcin Siwek; Dominika Dudek; Grzegorz Maczka; Andrzej Zieba
Journal:  Psychiatr Pol       Date:  2007 May-Jun       Impact factor: 1.657

View more
  2 in total

1.  Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis.

Authors:  Andrew B Mendlowitz; Alaa Shanbour; Jonathan Downar; Fidel Vila-Rodriguez; Zafiris J Daskalakis; Wanrudee Isaranuwatchai; Daniel M Blumberger
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

2.  Prophylactic cognitive enhancers for improvement of cognitive function in patients undergoing electroconvulsive therapy: A systematic review and meta-analysis.

Authors:  Yunlian Niu; Dan Ye; Yijie You; Jian Wu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.